Cartesian Therapeutics (RNAC) Shares Outstanding (Diluted) (2014 - 2026)
Cartesian Therapeutics (RNAC) recorded Weighted Average Shares Outstanding (Diluted) of 29.86 million in Q2 2026, up 12.9% from 26.45 million a year earlier and up 11.2% from the prior quarter.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) Shares Outstanding (Diluted) (2014 - 2026) Analysis & Trends
For FY2025, Cartesian Therapeutics reported Weighted Average Shares Outstanding (Diluted) of 25.97 million, up 49.6% from FY2024.
- Annual Weighted Average Shares Outstanding (Diluted) has a five-year compound annual growth rate of -23.8% (FY2020 to FY2025).
- Across earlier years, Weighted Average Shares Outstanding (Diluted) came in at 17.36 million in FY2024 (-88.8%), 155.11 million in FY2023 (+6.3%), 145.87 million in FY2022 (+27.6%) and 114.33 million in FY2021 (+13.0%).
- The Q2 2026 figure is the highest quarterly Weighted Average Shares Outstanding (Diluted) since Q4 2023.
- On a year-over-year basis, Weighted Average Shares Outstanding (Diluted) has increased for six consecutive quarters, with growth averaging 42.4% over the last eight quarters.
- Peak year-over-year performance for Weighted Average Shares Outstanding (Diluted) in the last five years was growth of 378.4% in Q1 2025, against a decline of 96.5% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 26.86 million (Q1 2026), 25.97 million (Q4 2025) and 26 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Cartesian Therapeutics | 210.06 Mn | -304.30 Mn | - | 30.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 30.31 Mn |
| Jun 30, 2026 | 29.86 Mn |
| Mar 31, 2026 | 26.86 Mn |
| Dec 31, 2025 | 25.97 Mn |
| Sep 30, 2025 | 26.00 Mn |
| Jun 30, 2025 | 26.45 Mn |
| Mar 31, 2025 | 25.90 Mn |
| Dec 31, 2024 | 17.36 Mn |
| Sep 30, 2024 | 21.47 Mn |
| Jun 30, 2024 | 17.79 Mn |
| Mar 31, 2024 | 5.41 Mn |
| Dec 31, 2023 | 155.11 Mn |
| Sep 30, 2023 | 154.80 Mn |
| Jun 30, 2023 | 153.44 Mn |
| Mar 31, 2023 | 153.35 Mn |
| Dec 31, 2022 | 145.87 Mn |
| Sep 30, 2022 | 152.85 Mn |
| Jun 30, 2022 | 148.51 Mn |
| Mar 31, 2022 | 127.57 Mn |
| Dec 31, 2021 | 114.33 Mn |
API Access
Cartesian Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=RNAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "RNAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=RNAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();